The molecular oncology group of the Institute of Biodonostia, led by our CEO; Charles Lawrie, has managed to be at the forefront of the world in the fight against head and neck cancer thanks to a work in DNA biomarkers for the early detection of carcinoma of the larynx. The key to this work is[…]
Ana joins to Indicate solutions as our new CSO from CIC biomaGUNE. She worked on the development of technology in the CIC biomaGUNE laboratory.
The last 8th of November our CEO, Charles Lawrie, presented Indicate Solutions in the Imagine If competition, organized by the Innovation Forum Euskadi. We did not win, but we left with illusion for the generated expectation.
Yesterday, October 30, our CEO, Charles Lawrie made the last presentation of BStartup Health to Carlos Gallardo, Founder in CG Health Partners; Damià Tormo, CEO and Founder of Artax Biopharma Inc and Montse Vendrell, Partner in Alta Life Sciences. Now we have to wait for next week to see if our roads come together!!
IMAGINE IF! is the first truly global competition and accelerator program for deep technology organised by the Innovation Forum across our global branches where The best 15 global teams will pitch at the Innovation Forum – Leaders Conference 2018 in Cambridge (UK). Of course Indicate Solutions will try to be there!!
Indicate Solutions has participate the 16 – 17 October 2018 in San Sebastián, Spain in the 4th Bio-Health Industry Meetings. The aim of the event is to promote cross-border projects in collaboration between industrialists and researchers from public and private entities of the health sector. The Meetings were aimed at entrepreneurs, researchers, university students and, in general,[…]
Indicate Solutions is among the ten finalists of BStartup and will have to go 30th October for final presentation!!
The NEOTEC application was submitted the 2th October (phew!). It has been a gargantuan effort for everyone involved. So thank you to all the members/collaborators. Now fingers crossed !!!!!
Javier joins Indicate Solutions as our new BDM having come from Tecnalia Ventures. He will be working in collaboration with Charles Lawrie in BIC Gipuzkoa, in the development of the business and its subsequent commercialization.
María joins Indicate Solutions as our new CSO having come from the lab of Luis Liz Marzán in CIC biomaGUNE. Maria is an expert in nucleic acid chemistry and nanoparticle synthesis. She will be working in collaboration with Marek in DIPC and coordinating the scientific management with IS